Rhythm Biosciences
Rhythm Biosciences (ASY:RHY) is transforming cancer diagnostics through innovative diagnostic technologies that predict, detect, characterise, and support early intervention. Our mission goes beyond testing, we're creating a comprehensive approach to understanding cancer risk, enabling earlier treatment, and ultimately saving lives.
Unlike traditional screening methods that are invasive, uncomfortable, and often avoided, we’re developing precise and accessible screening solutions, that empower patients and healthcare systems with critical insights.
Rhythm is not just a medical technology company, we’re health innovators driven by a singular purpose. Our work is about knowledge, reducing unnecessary medical procedures, alleviating the strain on healthcare systems, and most importantly, giving people the earliest possible chance to take control of their health.
